Dalpiciclib in HR+/HER2- ABC

RecruitingOBSERVATIONAL

Enrollment

103

Participants

Timeline

Start Date

May 3, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2028

Conditions

Advanced Breast Cancer

Interventions

DRUG

dalpiciclib

dalpiciclib oral day 1-21, every 28 days

Trial Locations (1)

RECRUITING

Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai

All Listed Sponsors

lead

RenJi Hospital

OTHER